Zhejiang Jingxin Pharmaceutical Co.,Ltd.’s Net Profit Rose 7% in First Half of 2022

Zhejiang Jingxin Pharmaceutical Co.,Ltd. (浙江京新药业股份有限公司) (002020.SZ) reported a net profit of 299.3 million yuan in the first half of 2022, up 7% year-on-year.

Meanwhile, the company posted 1.9 billion yuan in revenue, up 8.5% year-on-year.

At the end of the reporting period, it had 6.7 billion yuan in total assets and 1.9 billion yuan in total liabilities, with a liability-to-asset ratio of 28.2%.